Tus yuam sij rau kev ua tau zoo ntawmIGF-1 LR3 Tabletnyob rau hauv nws txoj kev khi rau qhov tshwj xeeb receptor IGF1R. IGF1R yog ib tug transmembrane tyrosine kinase receptor dav faib rau saum npoo ntawm ntau lub hlwb nyob rau hauv tib neeg lub cev, nrog rau cov leeg hlwb, pob txha hlwb, adipocytes, thiab lwm yam. Thaum IGF-1 LR3 khi rau IGF1R, nws activates lub receptor tus kheej tyrosine kinase kev ua si, triggering receptorryphosphosphate. Cov txheej txheem no zoo li tus yuam sij qhib lub "qhov rooj" ntawm intracellular teeb liab transduction, pib ib tug series ntawm complex intracellular teeb liab transduction txoj kev. AKT signaling txoj kev yog ib qho tseem ceeb ntawm kev taw qhia txoj hauv kev rau IGF-1 LR3 ua kom. Thaum IGF1R tau qhib, nws yuav kis tau los ntawm cov xov tooj ntawm cov teeb liab nruab nrab, thaum kawg ua kom AKT protein. Cov activated AKT protein tuaj yeem nkag mus rau hauv lub nucleus thiab tswj cov kev qhia ntawm ntau yam noob.
Peb cov khoom los ntawm
IGF-1 LR3 COA
Lub cev thiab tshuaj lom neeg ntawm IGF-1 LR3 ntsiav tshuaj thiab qhov ncauj Protein xa
Lub cev thiab tshuaj lom neeg cov teeb meem ntawm qhov ncauj kev xa cov protein
Lub complexity ntawm lub plab hnyuv ib puag ncig
Qhov kev sib tw tseem ceeb ntawm kev xa cov protein ntawm qhov ncauj yog qhov nyuaj ntawm lub plab zom mov ib puag ncig. Muaj ntau yam teeb meem ntawm lub cev thiab tshuaj lom neeg hauv lub plab zom mov, suav nrog kev degradation enzymatic, hloov pH, cov hnyuv hauv plab tuav, thiab txwv txoj hnyuv epithelial permeability. Cov teeb meem no tuaj yeem hloov pauv qhov muaj pes tsawg leeg thiab cov qauv ntawm cov protein, ua rau poob ntawm lawv cov kev ua haujlwm lom neeg.
Enzymatic degradation: Lub plab hnyuv muaj ntau yam proteases thiab peptidases, xws li pepsin, trypsin, thiab chymotrypsin, uas tuaj yeem txo qis cov tshuaj noj protein sai sai, ua rau lawv tsis muaj zog.
Kev hloov pauv PH tus nqi: Tus nqi pH hauv plab hnyuv tau hloov pauv los ntawm cov kua qaub muaj zog hauv plab (pH 1.5-3.5) kom tsis muaj zog alkalinity hauv cov hnyuv (pH 6.0-7.4). Qhov kev hloov pauv pH no tuaj yeem cuam tshuam rau kev solubility thiab ruaj khov ntawm cov protein, ua rau lawv cov nag lossis daus.
Cov kab mob hauv plab hnyuv: Cov kab mob hauv plab hnyuv yog tsim los ntawm mucopolysaccharides thiab cov proteins, ua rau lub cev tsis muaj zog uas txwv cov tshuaj protein nkag mus rau hauv cov hlab ntsha los ntawm cov kab mob hauv plab hnyuv.
Tsawg permeability ntawm plab hnyuv epithelium: Lub kaw ntom nti ntawm cov hnyuv epithelial hlwb txwv kev nkag mus ntawm cov tshuaj protein ntau, ua rau nws nyuaj rau lawv nkag mus rau cov hlab ntsha los ntawm txoj hnyuv mucosa.
Lub cev thiab tshuaj stability ntawm cov protein
Lub cev thiab tshuaj lom neeg ruaj khov ntawm cov tshuaj protein yog lwm qhov kev sib tw loj rau lawv qhov ncauj. Proteins yog rhiab heev rau tshav kub, ions (acids, bases, hlau ions), organic solvents, thiab lwm yam sab nraud yam, thiab nws yog nquag mus rau denaturation, sib sau ua ke, thiab nag lossis daus tshwm sim, yog li poob lawv lom lom.
Thermal stability: Proteins yog nquag mus rau denaturation ntawm qhov kub thiab txias, ua rau kev puas tsuaj ntawm lawv cov qauv tertiary thiab poob ntawm lom lom. Yog li ntawd, cov tshuaj protein yuav tsum tau tswj qhov kub thiab txias thaum lub sij hawm npaj, cia, thiab kev thauj mus los.
Ionic stability: Proteins rhiab heev rau kev hloov pauv hauv ion concentration thiab pH tus nqi hauv kev daws, thiab kev hloov hauv ion zog tuaj yeem cuam tshuam rau kev solubility thiab ruaj khov ntawm cov protein.
Organic solvent stability: Nyob rau hauv cov txheej txheem ntawm kev npaj cov tshuaj protein, nws yog ib qho tsim nyog yuav tau siv cov kuab tshuaj organic rau kev sib cais thiab purification. Txawm li cas los xij, cov kuab tshuaj organic tuaj yeem cuam tshuam rau theem nrab thiab qib theem ntawm cov proteins, ua rau txo qis hauv lawv cov kev ua haujlwm lom neeg.
Tsim thiab Optimization ntawm Delivery System
Txhawm rau kom kov yeej cov teeb meem ntawm lub cev thiab tshuaj lom neeg ntawm cov khoom noj ntawm qhov ncauj, cov kws tshawb fawb tau tsim ntau yam kev xa khoom, xws li lipid raws li cov neeg nqa khoom, cov tshuab polymer, tshuab mucosal adhesion, thiab cov tshuab xa khoom ntse. Txawm li cas los xij, kev tsim thiab kev ua kom zoo ntawm cov tshuab xa khoom no tseem ntsib ntau yam teeb meem.
Kev xaiv cov cab kuj: Cov xa khoom sib txawv muaj qhov sib txawv encapsulation efficiency, ruaj khov, thiab cov yam ntxwv ua haujlwm. Xaiv cov cab kuj tsim nyog yog qhov tseem ceeb rau kev txhim kho qhov ncauj bioavailability ntawm cov tshuaj protein.
Cov txheej txheem ntim khoom: Cov txheej txheem ntim cov tshuaj protein yuav tsum muaj kev tswj hwm nruj kom tsis txhob muaj cov protein denaturation lossis degradation. Lub caij no, cov txheej txheem ntim kuj yuav tsum xav txog lub peev xwm thauj khoom thiab tso tawm cov yam ntxwv ntawm cov cab kuj.
Intelligent delivery system: Lub tshuab xa khoom ntse tuaj yeem teb rau cov kev xav ntawm lub cev lossis ib puag ncig (xws li pH tus nqi, kev ua haujlwm enzyme, qhov kub thiab txias, thiab lwm yam) los tswj kev tso tawm cov tshuaj protein. Txawm li cas los xij, kev tsim thiab kev ua kom zoo tshaj plaws ntawm kev xa khoom ntse yuav tsum muaj kev nkag siab tob txog kev sib cuam tshuam ntawm cov tshuaj protein thiab cov nqa khoom.
Qhov teeb meem ntawm "loj barrier" nyob rau hauv qhov nqus ntawm IGF-1 LR3 ntsiav tshuaj
IGF-1 LR3 Tablet, raws li ib tug loj molecule protein tshuaj, ntsib lub cev muaj zog cov kev txwv nyob rau hauv cov nqe lus ntawm loj molecule permeation thaum lub sij hawm lub qhov ncauj. Kev sib txuas nruj ntawm cov kab mob hauv plab hnyuv thiab plab hnyuv epithelial hlwb tsim ib qho insurmountable "loj barrier" uas cuam tshuam IGF-1 LR3 los ntawm kev nkag mus rau hauv cov hlab ntsha los ntawm txoj hnyuv mucosa.
Kev ua haujlwm ntawm cov kab mob hauv plab hnyuv: Cov kab mob hauv plab hnyuv yog tsim los ntawm mucopolysaccharides thiab cov proteins, ua rau lub cev tsis muaj zog uas nws qhov pore loj txwv kev nkag mus ntawm cov tshuaj macromolecular protein. Qhov hnyav molecular ntawm IGF-1 LR3 yog qhov loj, ua rau nws nyuaj rau nkag mus rau hauv cov hnyuv epithelial hlwb los ntawm qhov pores ntawm cov hnyuv mucus txheej.
Kev txwv nruj ntawm kev sib txuas ntawm cov plab hnyuv epithelial: Cov kev sib tshuam nruj ntawm cov plab hnyuv epithelial ntxiv txwv kev nkag mus ntawm cov tshuaj macromolecular protein. Cov kev sib txuas nruj no yog tsim los ntawm ntau cov proteins, tsim ib qho kev tiv thaiv tsis zoo uas ua rau nws nyuaj rau IGF-1 LR3 nkag mus rau hauv cov hlab ntsha los ntawm txoj hnyuv epithelial hlwb.
Kev sib raug zoo ntawm molecular loj thiab kev nqus tshuaj
Qhov loj ntawm cov tshuaj molecules yog ib qho tseem ceeb ntawm kev cuam tshuam rau lawv qhov nqus. Feem ntau hais lus, cov lus hais tias cov tshuaj uas muaj qhov loj me me yog yooj yim absorbed los ntawm plab hnyuv mucosal hlwb tsis raug. Qhov tseeb, cov tshuaj molecule loj feem ntau muaj teeb meem nkag mus rau cov kab mob lom neeg xws li cell membranes thiab plab hnyuv mucosa. Ntawm qhov tsis sib xws, cov tshuaj me me tau yooj yim pom tau los ntawm cov receptors ntawm cov cell membrane thiab nkag mus rau hauv lub cell, yog li muaj bioavailability ntau dua.
Kev sib raug zoo ntawm solubility thiab molecular loj: qhov loj ntawm cov tshuaj molecule loj, nws cov solubility qis dua. Qhov no yog vim cov tshuaj loj dua molecules xav tau ntau qhov chaw kom haum lawv cov qauv, yog li txo cov solubility ntawm cov tshuaj hauv dej. IGF-1 LR3, raws li ib tug loj molecule protein tshuaj, muaj tsawg solubility thiab yog ib qho nyuaj rau tsim ib tug txaus concentration gradient nyob rau hauv lub plab hnyuv ib ntsuj av, uas cuam tshuam rau nws nqus.
Kev sib raug zoo ntawm kev ruaj ntseg thiab molecular loj: qhov loj ntawm cov tshuaj molecule loj, qhov tsis zoo ntawm nws cov stability nyob rau hauv cov tshuaj xa system. Cov tshuaj loj dua molecules muaj ntau dua rau kev sib sau thiab nag lossis daus, yog li cuam tshuam rau lawv qhov nqus. IGF-1 LR3 tej zaum yuav cuam tshuam los ntawm enzymatic degradation, pH hloov, thiab lwm yam nyob rau hauv lub plab zom mov, ua rau kom txo nws cov stability thiab ntxiv rau nws nqus.
Kev sib raug zoo ntawm bioavailability thiab molecular loj: Qhov loj dua qhov loj ntawm cov tshuaj molecular, qhov dav nws qhov kev faib tawm ntau hauv lub cev, tab sis nws kuj yuav metabolized thiab tso tawm sai dua, yog li txo cov bioavailability ntawm cov tshuaj. IGF-1 LR3, raws li ib tug loj molecule protein tshuaj, muaj tsawg bioavailability thiab yog tsis yooj yim sua kom ua tau zoo kev kho mob concentrations nyob rau hauv vivo.
Lub tswv yim ntawm kev tawg los ntawm "loj barrier" ntawm IGF-1 LR3 ntsiav tshuaj nqus
Nyob rau hauv thiaj li yuav kov yeej qhov "size barrier" teeb meem ntawmIGF-1 LR3 tabnqus tau, tus xa khoom tshiab tuaj yeem siv los txhim kho nws txoj kev ruaj ntseg thiab bioavailability. Piv txwv li, silk protein raws li cov khoom xa tuaj muaj biocompatibility zoo heev, tsis muaj tshuaj lom, thiab dej ua haujlwm, thiab tuaj yeem thauj khoom thiab xa cov tshuaj peptide thiab cov tshuaj protein yam tsis muaj kev cuam tshuam rau lawv cov haujlwm. Kev sib cuam tshuam ntawm silk protein thiab cov tshuaj muaj protein ntau kuj muaj kev ua haujlwm ntawm stabilizing cov tshuaj protein, uas tuaj yeem tiv thaiv kev nthuav tawm ntawm cov tshuaj protein hauv cov tshuaj, cov khoom siv, thiab hauv vivo, thiab txhim kho lawv cov bioavailability.
Txhim kho cov txheej txheem npaj ntsiav tshuaj
Optimizing cov txheej txheem npaj ntsiav tshuaj kuj tseem ceeb rau kev txhim kho qhov ncauj bioavailability ntawm IGF-1 LR3. Tsis tshua muaj kub granulation thiab ziab cov txheej txheem, sib tov me me thiab granulation cov tswv yim, thiab optimized ntsiav tshuaj nias txheej txheem tsis tau siv los txo cov kev puas tsuaj ntawm kub kub, siab kub, thiab mechanical quab yuam ntawm IGF-1 LR3. Lub caij no, cov txheej txheem txheej txheej enteric kuj tuaj yeem siv los tiv thaiv IGF-1 LR3 los ntawm kev puas tsuaj los ntawm gastric acid thiab tso cov tshuaj kom ruaj khov hauv cov hnyuv.
Ua ke nrog kev xa khoom ntse
Kev sib txuas cov tshuab xa khoom ntse kuj yog ib lub tswv yim zoo los rhuav tshem "loj barrier" ntawmIGF-1 LR3 tabnqus. Lub tshuab xa khoom ntse tuaj yeem teb rau qhov tshwj xeeb ntawm lub cev lossis ib puag ncig stimuli (xws li pH tus nqi, enzyme kev ua, kub, thiab lwm yam) los tswj kev tso tawm ntawm IGF-1 LR3. Piv txwv li, pH teb cov khoom ntse ntse tuaj yeem siv los tiv thaiv cov ntsiav tshuaj los ntawm kev yaj hauv plab thiab tso cov tshuaj tsuas yog tom qab ncav cuag txoj hnyuv; Xwb, enzyme teb cov khoom siv ntse tuaj yeem siv los tso tshuaj los ntawm cov ntsiav tshuaj raws li kev ua ntawm cov enzymes tshwj xeeb. Cov tshuab xa khoom ntse no tuaj yeem txhim kho lub qhov ncauj bioavailability thiab kho cov txiaj ntsig ntawm IGF-1 LR3.
Siv cov cuab yeej siv mucosal adhesion
Mucosal adhesion technology yog ib txoj hauv kev txhim kho kev nqus tshuaj los ntawm kev txhim kho kev sib cuam tshuam ntawm cov tshuaj thiab cov hnyuv mucosa. Polymers nrog mucosal adhesion tuaj yeem siv los ua cov khoom thauj mus rau encapsulate IGF-1 LR3, tsim cov mucosal adhesion formulations. Qhov kev npaj no tuaj yeem ua kom ntev lub sijhawm nyob ntawm cov tshuaj nyob rau hauv plab hnyuv mucosa, nce qhov chaw sib cuag ntawm cov tshuaj thiab cov hnyuv mucosa, thiab yog li txhim kho kev nqus ntawm cov tshuaj.
Tshawb nrhiav Nanotechnology
Nanotechnology muab cov tswv yim tshiab rau kev xa cov tshuaj protein hauv qhov ncauj. Los ntawm kev npaj IGF-1 LR3 rau hauv nanoparticles lossis nanoemulsions, nws cov solubility thiab stability tuaj yeem txhim kho tau zoo, thiab nws lub peev xwm nkag mus rau hauv plab hnyuv mucosa tuaj yeem txhim kho. Nanoformulations muaj qhov me me me me thiab loj dua qhov chaw ntawm qhov chaw, ua kom yooj yim rau nkag mus rau hauv qhov nruj junctions ntawm cov hnyuv mucus txheej thiab plab hnyuv epithelial hlwb, yog li txhim kho cov bioavailability ntawm cov tshuaj.
Cim npe nrov: Tuam Tshoj igf-1 lr3 ntsiav tshuaj manufacturers, lwm tus neeg
